There are many factors that can affect the health of a company. This is one reason why stock trading can be extremely difficult at times. Because there are always so many things to take into consideration, it may be next to impossible to create a formula that will continually beat the market. Even after all the data has been scrutinized and the numbers have been crunched, the investor still has to make sense of the information and figure out what to do with it. Knowing how to use the information about publically traded companies can end up being the difference between handsome gains and devastating losses. 

Technical traders have many tools at their disposal when conducting stock research. One of those tools is the Exponential Moving Average or EMA. The EMA is similar to the simple moving average, but more weight is put on the newest data. Let’s look at some different EMA levels on shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY):

10 day Exponential Moving Average: 83.95497391
20 day Exponential Moving Average: 83.22443503
30 day Exponential Moving Average: 82.65118617
50 day Exponential Moving Average: 81.5281768
100 day Exponential Moving Average: 79.43918563
200 day Exponential Moving Average: 78.52044304

Following trading action on shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), we see that the stock has moved 2.18 since the opening price of 83.14. So far, the stock has reached a high of 85.69 and dipped to a low of 83.04. The consensus rating on the stock is currently Strong Buy, and today’s volume has been measured around 214691.

Tracking some stock ratings, we can see that the stock’s Moving Average Rating is currently pointing to a “Strong Buy”. Traders may be monitoring many different indicators in order to get a grasp of where the stock may be moving in the near future. Taking a look at the Oscillators rating, we note that the reading is pointing to a “Buy”.

Traders will take note of the 20 day Chaikin Money Flow indicator that is now at 0.01657916. The value of this indicator will fluctuate between 1 and -1. Traders may be watching when the CMF crosses zero. This cross might point to a bullish or bearish price reversal depending on which way it is moving crossing the zero line.

There are a number of different pivot points that traders can use when conducting stock analysis. Pivot points can be useful for traders looking to establish trading entry and exit points. Focusing on some popular one month pivots, we see that the Woodie pivot is currently at 81.0825. The Woodie support 1 pivot is 77.215, and the Woodie resistance 1 pivot is 82.425. The Camarilla one month pivot is presently 81.49333333. The one month Classic pivot is 81.49333333 and the Classic resistance 1 is 83.24666667 while the Classic support 1 pivot is measured at 78.03666667.

The Awesome Oscillator reading is currently 2.32083382 for on shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Technical traders will watch the AO especially when it crosses above or below the zero line. A move above the line may signal a bullish scenario. A move below the zero line may indicate a bearish selling opportunity. The AO may prove to be a valuable tool for many momentum traders.

Taking a look at the Donchian Channels indicator, we note that the 20 day lower band is 78.52. The 20 day upper band is 86.98. This indicator was created by Richard Donchian, and traders follow these channels to help identify potential trading signals.

There are many factors that can affect the health of a company. This is one reason why stock trading can be extremely difficult at times. Because there are always so many things to take into consideration, it may be next to impossible to create a formula that will continually beat the market. Even after all the data has been scrutinized and the numbers have been crunched, the investor still has to make sense of the information and figure out what to do with it. Knowing how to use the information about publically traded companies can end up being the difference between handsome gains and devastating losses. 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.